European Journal of Organic Chemistry
10.1002/ejoc.201801062
FULL PAPER
(E)-3,3-Dimethyl-1-(5-methyl-1,1-dioxo-2-phenyl-1,2-benzothiazol-3(2H)-
Ethyl
(E)-2-(5-nitro-1,1-dioxo-2-phenyl-1,2-benzothiazol-3(2H)-
ylidene)butan-2-one [(E)-2b]. (E)-1,2-Benzothiazoledione 2b was
prepared according to general procedure using sulfonyl ynamine 1b (355
ylidene)acetate [(E)-2i]. (E)-1,2-Benzothiazoledione 2i was prepared
according to general procedure using sulfonyl ynamine 1i (375 mg, 1.0
mmol). Ratio E/Z > 99:1 was determined by 1H NMR spectroscopy.
mg, 1.0 mmol). Ratio E/Z
spectroscopy. Column chromatography (toluene; silica gel was washed
with 1% Et N in heptane before being used for column chromatography)
afforded the product (E)-2b as a white solid (121 mg, 34%). R (silica gel,
solution). H NMR [400 MHz, δ (ppm),
]: 1.05 (s, 9 H), 2.57 (s, 3 H), 5.71 (s, 1 H), 7.48–7.53 (m, 2 H),
.54–7.65 (m, 4 H), 7.82 (d, J = 7.9 Hz, 1 H), 9.10 (quint, J = 0.6 Hz, 1 H).
]: 22.3, 26.8, 44.7, 101.5, 121.0,
>
99:1 was determined by 1H NMR
Column chromato-graphy (toluene; silica gel was washed with 1% Et
heptane before being used for column chromatography) afforded the
product (E)-2i as a white solid (113 mg, 30%). R (silica gel, toluene):
0.28 (UV, KMnO ]: 1.28 (t,
solution). 1H NMR [400 MHz, δ (ppm), CDCl
3
N in
3
F
F
1
toluene): 0.28 (UV, KMnO
CDCl
4
4
3
3
J = 7.1 Hz, 3 H), 4.24 (q, J = 7.1 Hz, 2 H), 5.27 (s, 1 H), 7.46–7.56 (m, 2
H), 7.58–7.69 (m, 3 H), 8.12 (d, J = 8.5 Hz, 1 H), 8.61 (dd, J = 8.5, 1.9 Hz,
7
1
3C NMR [101 MHz, δ (ppm), CDCl
1 H), 10.43 (d, J = 1.9 Hz, 1 H). 13C NMR [101 MHz, δ (ppm), CDCl
3
3
]:
1
27.8, 129.4, 130.4, 130.5, 130.6, 130.8, 130.9, 133.4, 145.1, 145.6,
14.2, 61.2, 99.9, 122.5, 125.6, 127.3, 129.1, 129.6, 130.7, 130.9, 131.1,
204.3. FTIR [ν
̅
(cm−1)]: 695, 966, 1078, 1183, 1322, 1566, 1673, 2965.
137.6, 143.8, 151.2, 165.6. FTIR [ν
̅
(cm−1)]: 694, 740, 1095, 1113, 1186,
+
+
HRMS (ESI-TOF) m/z: [M + H] calcd. for C20
3
H23NO S 356.1320, found
1341, 1537, 1706, 2926, 3111. HRMS (ESI-TOF) m/z: [M + H] calcd. for
356.1343.
17 16 2 6
C H N O S 375.0651, found 375.0667.
(
E)-2-(5-methyl-1,1-dioxo-2-phenyl-1,2-benzothiazol-3(2H)-ylidene)-1-
phenylethan-1-one [(E)-2c]. (E)-1,2-Benzothiazoledione 2c was
prepared according to general procedure using sulfonyl ynamine 1c (375
mg, 1.0 mmol). Ratio E/Z
98:2 was determined by 1H NMR
spectroscopy. Column chromatography (toluene; silica gel was washed
with 1% Et N in heptane before being used for column chromatography)
afforded the product (E)-2c as a white solid (116 mg, 31%). R (silica gel,
toluene): 0.31 (UV, KMnO
solution). 1H NMR [400 MHz, δ (ppm),
CDCl ]: 2.57 (s, 3 H), 6.09 (s, 1 H), 7.37–7.45 (m, 2 H), 7.48–7.55 (m, 1
H), 7.56–7.66 (m, 6 H), 7.72–7.79 (m, 2 H), 7.85 (d, J = 8.0 Hz, 1 H),
Ethyl
(E)-2-(2,5-dimethyl-1,1-dioxo-1,2-benzothiazol-3(2H)-
ylidene)acetate [(E)-2j]. (E)-1,2-Benzothiazoledione 2j was prepared
according to general procedure using sulfonyl ynamine 1j (281 mg, 1.0
mmol). Ratio E/Z = 95:5 was determined by 1H NMR spectroscopy.
Column chromato-graphy (toluene; silica gel was washed with 1% Et
heptane before being used for column chromatography) afforded the
product (E)-2j as colorless oil (87 mg, 31%). R (silica gel, toluene): 0.23
solution). 1H NMR [400 MHz, δ (ppm), CDCl
(UV, KMnO ]: 1.35 (t, J =
=
3
N in
3
F
F
4
4
3
3
7.1 Hz, 3 H), 2.54 (s, 3 H), 3.15 (s, 3 H), 4.25 (q, J = 7.1 Hz, 2 H), 5.33 (s,
1 H), 7.50 (d, J = 7.9 Hz, 1 H), 7.76 (d, J = 7.9 Hz, 1 H), 9.17 (s, 1 H). 13C
9
1
1
1
.00 (quint, J = 0.5 Hz, 1 H). 13C NMR [101 MHz, δ (ppm), CDCl
02.4, 121.1, 127.4, 127.7, 128.2, 128.6, 129.1, 130.5, 130.6, 130.7,
30.9, 132.8, 133.6, 139.4, 145.1, 146.4, 189.7. FTIR [ν
(cm−1)]: 696, 959,
3
]: 22.2,
NMR [101 MHz, δ (ppm), CDCl
127.9, 129.8, 130.5, 132.7, 144.8, 144.9, 166.0. FTIR [ν
3
]: 14.3, 22.2, 26.5, 60.5, 95.0, 120.8,
(cm−1)]: 701, 823,
̅
̅
1039, 1137, 1159, 1315, 1619, 1708, 2982. HRMS (ESI-TOF) m/z: [M +
+
185, 1323, 1565, 1653, 1724, 2922, 3064. HRMS (ESI-TOF) m/z: [M +
H] calcd. for C13
4
H17NO S 282.0800, found 282.0819.
+
H] calcd. for C22
3
H19NO S 376.1007, found 376.1015.
Ethyl
ylidene)acetate
methylbenzenesulfonyl)isoindolin-1-ylidene]acetate
Benzothiazoledione 2k and compound 6 were prepared according to
general procedure using sulfonyl ynamine 1k (357 mg, 1.0 mmol). Ratio
(E)-2-(2-benzyl-5-methyl-1,1-dioxo-1,2-benzothiazol-3(2H)-
Ethyl (E)-2-(1,1-dioxo-2-phenyl-1,2-benzothiazol-3(2H)-ylidene)acetate
(E)-2g]. (E)-1,2-Benzothiazoledione 2g was prepared according to
general procedure using sulfonyl ynamine 1g (330 mg, 1.0 mmol). Ratio
E/Z
98:2 was determined by 1H NMR spectroscopy. Column
chromatography (toluene; silica gel was washed with 1% Et N in heptane
before being used for column chromatography) afforded the product (E)-
[(E)-2k]
and
ethyl
(E)-2-[2-(4-
[
(6).
(E)-1,2-
=
99:1 was determined by 1H NMR spectroscopy. Column
N in heptane
3
E/Z
>
chromatography (toluene; silica gel was washed with 1% Et
3
2
g as a white solid (112 mg, 34%). R
F
(silica gel, toluene): 0.31 (UV,
before being used for column chromatography) afforded the product (E)-
2k as a white solid (93 mg, 26%) and product 6 as a colorless oil (36 mg,
1
KMnO
4
solution). H NMR [400 MHz, δ (ppm), CDCl ]: 1.28 (t, J = 7.1 Hz,
3
3
7
H), 4.20 (q, J = 7.1 Hz, 2 H), 5.16 (s, 1 H), 7.46–7.56 (m, 2 H), 7.57–
.67 (m, 3 H), 7.76–7.85 (m, 2 H), 7.92–8.02 (m, 1 H), 9.44 (m, 1 H). 13C
10%). Compound (E)-2k: R
F
(silica gel, toluene): 0.30 (UV, KMnO
4
solution). 1H NMR [400 MHz, δ (ppm), CDCl
3
]: 1.26 (t, J = 7.1 Hz, 3 H),
NMR [101 MHz, δ (ppm), CDCl
30.5, 130.6, 130.7, 131.2, 132.5, 133.3, 133.9, 146.2, 166.3. FTIR [ν
cm−1)]: 692, 910, 1045, 1099, 1157, 1186, 1324, 1619, 1708, 2925.
HRMS (ESI-TOF) m/z: [M + H]+ calcd. for C17
S 330.0800, found
30.0827.
3
]: 14.4, 60.7, 97.6, 121.3, 127.4, 129.9,
2.53 (s, 3 H), 4.15 (q, J = 7.1 Hz, 2 H), 4.84 (s, 2 H), 5.28 (s, 1 H), 7.27–
7.33 (m, 1 H), 7.34–7.40 (m, 2 H), 7.40–7.44 (m, 2 H), 7.52 (dd, J = 7.9,
1
(
̅
0.6 Hz, 1 H), 7.81 (d, J = 7.9 Hz, 1 H), 9.13 (quint, J = 0.6 Hz, 1 H). 13
C
H17NO
4
3
NMR [101 MHz, δ (ppm), CDCl ]: 14.4, 22.4, 44.5, 60.6, 96.5, 121.0,
127.2, 127.8, 128.1, 129.1, 130.1, 130.4, 132.9, 134.1, 143.7, 145.1,
3
1
2
3
66.0. FTIR [ν
̅
(cm−1)]: 670, 732, 831, 1136, 1168, 1311, 1626, 1706,
+
986, 3098. HRMS (ESI-TOF) m/z: [M + H] calcd. for C19
4
H21NO S
Ethyl
(E)-2-(5-methoxy-1,1-dioxo-2-phenyl-1,2-benzothiazol-3(2H)-
58.1113, found 358.1118. Compound 6: R
solution). 1H NMR [400 MHz, δ (ppm), CDCl
7.1 Hz, 3 H), 2.40 (s, 3 H), 4.19 (q, J = 7.1 Hz, 2 H), 5.02 (s, 2 H), 6.43 (s,
H), 7.28–7.39 (m, 4 H), 7.41–7.47 (m, 1 H), 7.76–7.83 (m, 2 H), 9.13 (d,
J = 8.1 Hz, 1 H). 13C NMR [101 MHz, δ (ppm), CDCl
]: 14.6, 21.8, 55.4,
0.1, 96.7, 121.9, 127.7, 128.4, 128.9, 130.1, 131.3, 133.0, 134.6, 138.1,
F
(silica gel, toluene): 0.21
ylidene)acetate [(E)-2h]. (E)-1,2-Benzothiazoledione 2h was prepared
according to general procedure using sulfonyl ynamine 1h (360 mg, 1.0
mmol). Ratio E/Z = 95:5 was determined by 1H NMR spectroscopy.
(UV, KMnO
4
3
]: 1.32 (t, J =
1
Column chromatography (toluene; silica gel was washed with 1% Et
heptane before being used for column chromatography) afforded the
product (E)-2h as a white solid (119 mg, 33%). R (silica gel, toluene):
solution). 1H NMR [400 MHz, δ (ppm), CDCl
.17 (UV, KMnO ]: 1.25 (t,
J = 7.1 Hz, 3 H), 3.98 (s, 3 H), 4.16 (q, J = 7.1 Hz, 2 H), 5.12 (s, 1 H),
3
N in
3
6
F
145.1, 152.0, 167.0. FTIR [ν̅
(cm−1)]: 667, 800, 1089, 1165, 1344, 1620,
0
4
3
1
3
705, 2922. HRMS (ESI-TOF) m/z: [M + H]+ calcd. for C19
H21NO S
4
58.1113, found 358.1132.
7
7
.25 (dd, J = 8.7, 2.2 Hz, 1 H), 7.47–7.52 (m, 2 H), 7.53–7.64 (m, 3 H),
.83 (d, J = 8.6 Hz, 1 H), 9.14 (d, J = 2.3 Hz, 1 H). 13C NMR [101 MHz, δ
(
1
1
ppm), CDCl
3
]: 14.3, 56.1, 60.5, 97.2, 113.4, 119.7, 122.4, 125.1, 129.6,
Intramolecular Hydroarylation of 1d, 1e and 1f. Sulfonyl ynamines 1d,
1e or 1f were submitted to the reaction conditions according to general
procedure. 1H NMR spectroscopy of the crude product indicated partial
30.43, 130.49, 130.53, 131.0, 146.3, 164.0, 166.2. FTIR [ν
183, 1252, 1307, 1473, 1583, 1621, 1707, 2988, 3118. HRMS (ESI-
̅
(cm−1)]: 1103,
+
TOF) m/z: [M + H] calcd. for C18
5
H19NO S 360.0906, found 360.0919.
degradation
of
the
starting
material
to
4-methyl-N-
This article is protected by copyright. All rights reserved.